CORTEXA
← Browse
crossrefCancers2024-11-11Cited by 38

A Hybrid Deep Learning and Machine Learning Approach with Mobile-EfficientNet and Grey Wolf Optimizer for Lung and Colon Cancer Histopathology Classification

Raquel Ochoa-Ornelas, Alberto Gudiño-Ochoa, Julio Alberto García-Rodríguez

Background: Lung and colon cancers are among the most prevalent and lethal malignancies worldwide, underscoring the urgent need for advanced diagnostic methodologies. This study aims to develop a hybrid deep learning and machine learning framework for the classification of Colon Adenocarcinoma, Colon Benign Tissue, Lung Adenocarcinoma, Lung Benign Tissue, and Lung Squamous Cell Carcinoma from histopathological images. Methods: Current approaches primarily rely on the LC25000 dataset, which, due to image augmentation, lacks the generalizability required for real-time clinical applications. To address this, Contrast Limited Adaptive Histogram Equalization (CLAHE) was applied to enhance image quality, and 1000 new images from the National Cancer Institute GDC Data Portal were introduced into the Colon Adenocarcinoma, Lung Adenocarcinoma, and Lung Squamous Cell Carcinoma classes, replacing augmented images to increase dataset diversity. A hybrid feature extraction model combining MobileNetV2 and EfficientNetB3 was optimized using the Grey Wolf Optimizer (GWO), resulting in the Lung and Colon histopathological classification technique (MEGWO-LCCHC). Cross-validation and hyperparameter tuning with Optuna were performed on various machine learning models, including XGBoost, LightGBM, and CatBoost. Results: The MEGWO-LCCHC technique achieved high classification accuracy, with the lightweight DNN model reaching 94.8%, LightGBM at 93.9%, XGBoost at 93.5%, and CatBoost at 93.3% on the test set. Conclusions: The findings suggest that our approach enhances classification performance and offers improved generalizability for real-world clinical applications. The proposed MEGWO-LCCHC framework shows promise as a robust tool in cancer diagnostics, advancing the application of AI in oncology.

View free PDFSource page

Related papers

crossrefCancers2023-09-15Cited by 3

Machine Learning for Digital Scoring of PRMT6 in Immunohistochemical Labeled Lung Cancer

Abeer M. Mahmoud, Eileen Brister, Odile David, Klara Valyi-Nagy, Maria Sverdlov, Peter H. Gann, et al.

Lung cancer is the leading cause of cancer death in the U.S. Therefore, it is imperative to identify novel biomarkers for the early detection and progression of lung cancer. PRMT6 is associated with poor lung cancer prognosis. However, analyzing PRMT6 expression manually in large…

View free PDFSource page
crossrefCancers2024-06-28Cited by 7

Exploring Selenoprotein P in Liver Cancer: Advanced Statistical Analysis and Machine Learning Approaches

Ali Razaghi, Mikael Björnstedt

Selenoprotein P (SELENOP) acts as a crucial mediator, distributing selenium from the liver to other tissues within the body. Despite its established role in selenium metabolism, the specific functions of SELENOP in the development of liver cancer remain enigmatic. This study aims…

View free PDFSource page
crossrefCancers2024-09-20Cited by 22

A Novel Approach for Predicting the Survival of Colorectal Cancer Patients Using Machine Learning Techniques and Advanced Parameter Optimization Methods

Andrzej Woźniacki, Wojciech Książek, Patrycja Mrowczyk

Background: Colorectal cancer is one of the most prevalent forms of cancer and is associated with a high mortality rate. Additionally, an increasing number of adults under 50 are being diagnosed with the disease. This underscores the importance of leveraging modern technologies,…

View free PDFSource page
crossrefCancers2022-04-15Cited by 35

Deep Neural Networks and Machine Learning Radiomics Modelling for Prediction of Relapse in Mantle Cell Lymphoma

Catharina Silvia Lisson, Christoph Gerhard Lisson, Marc Fabian Mezger, Daniel Wolf, Stefan Andreas Schmidt, Wolfgang M. Thaiss, et al.

Mantle cell lymphoma (MCL) is a rare lymphoid malignancy with a poor prognosis characterised by frequent relapse and short durations of treatment response. Most patients present with aggressive disease, but there exist indolent subtypes without the need for immediate intervention…

View free PDFSource page
crossrefCancers2024-10-08Cited by 71

Learning from Imbalanced Data: Integration of Advanced Resampling Techniques and Machine Learning Models for Enhanced Cancer Diagnosis and Prognosis

Fatih Gurcan, Ahmet Soylu

Background/Objectives: This study aims to evaluate the performance of various classification algorithms and resampling methods across multiple diagnostic and prognostic cancer datasets, addressing the challenges of class imbalance. Methods: A total of five datasets were analyzed,…

View free PDFSource page
crossrefCancers2023-06-15Cited by 22

A Weakly Supervised Deep Learning Model and Human–Machine Fusion for Accurate Grading of Renal Cell Carcinoma from Histopathology Slides

Qingyuan Zheng, Rui Yang, Huazhen Xu, Junjie Fan, Panpan Jiao, Xinmiao Ni, et al.

(1) Background: The Fuhrman grading (FG) system is widely used in the management of clear cell renal cell carcinoma (ccRCC). However, it is affected by observer variability and irreproducibility in clinical practice. We aimed to use a deep learning multi-class model called SSL-CL…

View free PDFSource page